Fig. 5
From: Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma
The association between PLA2G7 and tumor progression. A: PLA2G7 overexpression was evident in 17 tumor tissue types, including DLBCL, relative to normal tissues as determined through GEPIA analyses. B: PLA2G7 expression in DLBCL patient samples and benign lymphadenitis tissue samples was compared. C and D: PLA2G7 expression in DLBCL samples with different stromal and immune scores was compared based upon the TCGA database